TrialPloS one2013

A randomized, non-inferiority study comparing efficacy and safety of a single dose of pegfilgrastim versus daily filgrastim in pediatric patients after autologous peripheral blood stem cell transplant.

Simone Cesaro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.